NCT03364387 (MINOCA-TR) is a clinical trial in Acute Coronary Syndrome, sponsored by Cardiovascular Academy Society, Turkey.

Who is sponsoring NCT03364387?

NCT03364387 is sponsored by Cardiovascular Academy Society, Turkey.

What condition does NCT03364387 study?

NCT03364387 studies Acute Coronary Syndrome, Myocardial Infarction, Atrial Fibrillation, Diabetes Mellitus.

Is NCT03364387 still recruiting?

NCT03364387 is currently completed. Last updated 24 July 2018.

Last reviewed 2018-07-24 · How we verify

NCT03364387: MINOCA-TR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population

Completed Last updated 24 July 2018

What this trial tests

trial in Acute Coronary Syndrome in 16,026 participants. Completed in 15 June 2018.

Timeline

5 March 2018

Primary endpoint
15 May 2018

15 June 2018

Quick facts

Lead sponsor	Cardiovascular Academy Society, Turkey
Status	Completed
Study type	OBSERVATIONAL
Enrollment	16,026
Start date	5 March 2018
Primary completion	15 May 2018
Estimated completion	15 June 2018
Sites	1 location across Turkey (Türkiye)

Conditions studied

Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →
Myocardial Infarction — all drugs for Myocardial Infarction →
Atrial Fibrillation — all drugs for Atrial Fibrillation →
Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

Cardiovascular Academy Society, Turkey

Who can join

Adults 18 to 90, any sex, with Acute Coronary Syndrome or Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to analyze the Demographics, Clinical Profiles, Management, in-Hospital and Long-Term Outcomes of Patients with Acute Coronary Syndrome Syndrome And Myocardial Infarction with Non-obstructive Coronary Artery Disease.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Prevalence and clinical profile of patients with myocardial infarction with non-obstructive coronary arteries in Turkey (MINOCA-TR): A national multi-center, observational study.
Kilic S, Aydın G, Çoner A, Doğan Y, et al · · 2020 · cited 20× · PMID 32120362 · DOI 10.14744/anatoljcardiol.2019.46805
Demographic, Clinical, and Angiographic Characteristics of Atrial Fibrillation Patients Suffering From de novo Acute Myocardial Infarction: A Subgroup Analysis of the MINOCA-TR Study Population.
Coner A, Ekmekci C, Aydin G, Kilavuz Dogan Y, et al · · 2021 · PMID 34950351 · DOI 10.4022/jafib.20200468

Verify or expand the search:

Other recruiting trials for Acute Coronary Syndrome

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
NCT07032389 — A Polypill for Acute Coronary Syndrome · Phase 2 · recruiting
NCT07102628 — Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar · Phase 3 · recruiting
NCT06416813 — Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques · NA · active not recruiting

Other Cardiovascular Academy Society, Turkey trials

Trials by the same sponsor.

NCT04275882 — Demographical and Clinical Profile of Patients With Left Ventricular Hypertrophy · completed
NCT03727984 — Re-hospitalized Patients With Acute Coronary Syndrome · completed
NCT03601013 — Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Tur · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03364387 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cardiovascular Academy Society, Turkey
Last refreshed: 24 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03364387.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing